Interventions to Reduce Pediatric Cancer Treatment Abandonment in Low- and Middle-Income Countries: A Scoping Review

Insights

Pediatric cancer treatment abandonment in low- and middle-income countries (LMICs) can be reduced with multifaceted interventions. Combining socioeconomic support, education, and improved clinical care significantly lowers abandonment rates and improves survival outcomes for children with cancer.

Area of Science:

  • Global Health
  • Pediatric Oncology
  • Health Services Research

Background:

  • Pediatric cancer outcomes in low- and middle-income countries (LMICs) are poor compared to high-income countries.
  • High treatment abandonment rates contribute significantly to this disparity.
  • Treatment abandonment is defined as failing to initiate or complete cancer therapy after diagnosis.

Purpose of the Study:

  • To conduct a scoping review of interventions aimed at reducing treatment abandonment in pediatric cancer patients in LMICs.
  • To identify and categorize interventions targeting treatment abandonment.
  • To evaluate the effectiveness of these interventions on abandonment rates and survival outcomes.

Main Methods:

  • Systematic database search for studies on interventions for pediatric cancer treatment abandonment in LMICs.
  • Inclusion criteria: interventions on treatment abandonment, patients ≤18 years, LMICs, pre- and post-intervention measures.
  • Interventions categorized into socioeconomic support, education/psychosocial support, or clinical care improvements.

Main Results:

  • 21 studies met inclusion criteria across WHO regions.
  • All interventions demonstrated a decrease in treatment abandonment.
  • Combined interventions (socioeconomic, psychosocial, clinical care) showed the largest reduction in abandonment (median ARR 16%, median RRR 72%).
  • Pre-intervention abandonment rate decreased from a median of 27% to 7% post-intervention.
  • 10 studies reported increased survival outcomes following interventions.

Conclusions:

  • Multifaceted interventions combining socioeconomic support, psychosocial support, and clinical care quality improvements are effective in reducing pediatric cancer treatment abandonment in LMICs.
  • Treatment abandonment is a modifiable challenge in LMICs.
  • Implementing comprehensive interventions can improve survival outcomes for children with cancer in resource-limited settings.
Abstract

Related Concept Videos

Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
212
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
650
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K
Methods Of Healthcare Delivery System01:26

Methods Of Healthcare Delivery System

At the different levels of the healthcare system, we see varying methods of healthcare used. These methods include managed care systems, case management, and primary healthcare.
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is...
4.0K